Boston to acquire forked stent developer AST is developing technology to address a significant,
This article was originally published in Clinica
Boston Scientific has agreed to acquire a small private company hard-to-treat subset of the coronary artery disease market. Advanced Stent Technologies (AST), of Pleasanton, California, has designed a stent to treat atherosclerosis where vessels branch into two. Boston says the device could be used in conjunction with its own drug-eluting stent (DES) technology.